Related Experiment Video
Updated: Jun 22, 2025

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel1, Coralie Werbrouck1, Michael Boettcher2
1School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Chimeric antigen receptor (CAR) T cell therapy shows promise for hematological cancers. Advanced CAR technologies aim to expand treatments beyond current limitations, addressing manufacturing bottlenecks and enabling personalized medicine.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Chimeric antigen receptor (CAR) T cell therapy is effective for advanced hematological cancers.
- CD19- and BCMA-CAR T therapies have achieved significant success, raising expectations for broader applications.
Purpose of the Study:
- To review the fundamental prerequisites, challenges, and strategies for extending CAR T cell therapy beyond current indications.
- To explore advanced CAR technologies for overcoming limitations of conventional CAR concepts.
Main Methods:
- Comprehensive review of existing literature and emerging CAR technologies.
- Analysis of innovations in combinatorial targeting and adapter CAR concepts.
- Discussion of next-generation CAR designs for multitargeted immunotherapies.
Main Results:
- Advanced CAR technologies, including combinatorial targeting and adapter CARs, offer solutions to antigen heterogeneity.
- These innovations promise to overcome CAR manufacturing bottlenecks.
- Patient-individualized treatment regimens are becoming more feasible with next-generation CAR designs.
Conclusions:
- The development of multitargeted immunotherapies using universal CAR technologies is a key future direction.
- Overcoming current limitations will pave the way for broader CAR T cell therapy applications.
- Strategic approaches are crucial for establishing the future of universal CAR technologies in cancer treatment.
Related Concept Videos
Otto and Diesel Cycle
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Internal Combustion Engine
Rolling Resistance: Problem Solving
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

